Peptide action in stroke therapy

Perturbing NMDA receptor interactions reduces ischemic brain damage without influencing neuronal transmission.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

N -methyl-D-aspartate receptors (NMDARs) mediate ischemic brain damage but blocking them is deleterious because these receptors also mediate essential neuronal excitation. In October 25 Science, Michelle Aarts and colleagues at the Toronto Western Hospital Research Institute, Toronto, Canada, show that perturbing NMDA receptor interactions with postsynaptic density protein PSD-95 may have a therapeutic effect on ischemic brain damage without influencing neuronal transmission (Science, 298:846-850, October, 25, 2002).

Aarts et al. transduced neurons with peptides that disrupted the interaction of NMDARs with the postsynaptic density protein PSD-95.They observed that this procedure dissociated NMDARs from downstream neurotoxic signaling without blocking synaptic activity or calcium in ?ux. In addition, application of the peptides either before or 1 hour after an insult, protected cultured neurons from excitotoxicity, reduced focal ischemic brain damage in rats, and improved their neurological function.

"Efficacy after the insult onset suggests targeting of the NMDAR–PSD-95 interaction as a practical future ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform